BMC Pharmacology and Toxicology, in partnership with Research Square, has launched In Review, a new option that provides authors with on-demand information on the status of their manuscript, enables them to share their work with funding bodies and their research community, and allows their colleagues to comment and collaborate - all whilst their manuscript is under review.
In Review
See your BMC Pharmacology and Toxicology manuscript’s review progress with our first-of-its-kind In Review service
Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript including seeing when reviewers are invited, and when reports are received
Annual Journal Metrics
-
Citation Impact
2.605 - 2-year Impact Factor (2021)
2.943 - 5-year Impact Factor (2021)
0.953 - SNIP (Source Normalized Impact per Paper)
0.497 - SJR (SCImago Journal Rank)Speed
48 days to first decision for all manuscripts (Median)
64 days to first decision for reviewed manuscripts only (Median)Usage
642,939 Downloads (2022)
402 Altmetric mentions (2021)
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication